These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29479764)

  • 1. How much can synthetic cannabinoid damage the heart? A case of cardiogenic shock following resistant ventricular fibrillation after synthetic cannabinoid use.
    Yamanoglu A; Celebi Yamanoglu NG; Evran T; Sogut O
    J Clin Ultrasound; 2018 Nov; 46(9):605-609. PubMed ID: 29479764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation following synthetic cannabinoid abuse.
    Efe TH; Felekoglu MA; Çimen T; Doğan M
    Turk Kardiyol Dern Ars; 2017 Jun; 45(4):362-364. PubMed ID: 28595208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial infarction associated with use of the synthetic cannabinoid K2.
    Mir A; Obafemi A; Young A; Kane C
    Pediatrics; 2011 Dec; 128(6):e1622-7. PubMed ID: 22065271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosis and synthetic cannabinoids.
    Deng H; Verrico CD; Kosten TR; Nielsen DA
    Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report positive for synthetic cannabinoids: are cardiovascular effects related to their protracted use?
    Anzillotti L; Marezza F; Calò L; Banchini A; Cecchi R
    Leg Med (Tokyo); 2019 Nov; 41():101637. PubMed ID: 31683096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Irreversible cardiogenic shock after captopril in a patient with refractory congestive cardiac insufficiency. Case report].
    Chocair PR; de Paula FJ; Ianhez LE; Sabbaga E
    Arq Bras Cardiol; 1983 Apr; 40(4):267-8. PubMed ID: 6362627
    [No Abstract]   [Full Text] [Related]  

  • 8. Can your heart handle the spice: A case of acute myocardial infarction and left ventricular apical thrombus.
    Shah M; Garg J; Patel B; Guthier J; Freudenberger RS
    Int J Cardiol; 2016 Jul; 215():129-31. PubMed ID: 27111175
    [No Abstract]   [Full Text] [Related]  

  • 9. International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids.
    Loeffler G; Delaney E; Hann M
    Brain Res Bull; 2016 Sep; 126(Pt 1):8-28. PubMed ID: 27108542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels.
    Al-Abri S; Meier KH; Colby JM; Smollin CG; Benowitz NL
    Clin Toxicol (Phila); 2014 Dec; 52(10):1292-5. PubMed ID: 25350468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case of law-evading herbs poisoning that induced shock and myocardial damage].
    Nakamura Y; Nakano M; Nakamura M; Miyazaki D; Okamori S; Akuzawa H; Yuasa M
    Chudoku Kenkyu; 2014 Dec; 27(4):333-8. PubMed ID: 25771668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic stroke associated with the use of a synthetic cannabinoid (spice).
    Moeller S; Lücke C; Struffert T; Schwarze B; Gerner ST; Schwab S; Köhrmann M; Machold K; Philipsen A; Müller HH
    Asian J Psychiatr; 2017 Feb; 25():127-130. PubMed ID: 28262132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorrhagic stroke following use of the synthetic marijuana "spice".
    Rose DZ; Guerrero WR; Mokin MV; Gooch CL; Bozeman AC; Pearson JM; Burgin WS
    Neurology; 2015 Sep; 85(13):1177-9. PubMed ID: 26320200
    [No Abstract]   [Full Text] [Related]  

  • 14. "Spice" girls: synthetic cannabinoid intoxication.
    Schneir AB; Cullen J; Ly BT
    J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrocardiographic aspects during irreversible, cardiogenic and non-cardiogenic circulatory arrest. Effect of attempted resuscitation therapy].
    Furlanello F; Stritoni P; Chioin R; Comelli LF; Permutti B; Nava A; Piccolo E
    Acta Anaesthesiol; 1970; 21(6):729-58. PubMed ID: 5538135
    [No Abstract]   [Full Text] [Related]  

  • 16. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
    White CM
    J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous ventricular assist device placement during active cardiopulmonary resuscitation for severe refractory cardiogenic shock after acute myocardial infarction.
    Idelchik GM; Loyalka P; Kar B
    Tex Heart Inst J; 2007; 34(2):204-8. PubMed ID: 17622370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitalisation associated with use of the synthetic cannabinoid K2.
    Glue P; Al-Shaqsi S; Hancock D; Gale C; Strong B; Schep L
    N Z Med J; 2013 Jun; 126(1377):18-23. PubMed ID: 23831873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.